I wasn't disagreeing with anything Legume, I should have noted your research was very good. I was actually pointing out it seems that Cahaba may have had the same thing and even doing the same tests in 2011. Not sure what happened to their results at this stage.
My query on the compound was mainly due to VHL and Cahaba being the only ones that have included monohydrate in the description, but I've had a look and of course they're all the same.
VHL note Data from a completed Phase 1 study of TCN-P in hematologic cancers (primarily Acute Myeloid Leukemia or AML) carried out at MD Anderson and Lee Moffitt Cancer Centers has shown encouraging anti-tumour activity.
I know different drugs are effective for different cancers and also may be ineffective on their own or very effective when combined with another treatment. This more recent 2011 study is relevant to the combination theory and references TCN-P:
Is that a little better than website ann's? TCN-P as a sole treatment from your 1993 or older studies, does appear toxic/ineffective, VHL appear to be using it in combination therapies, quite different method with very different results it would seem. Well, from what I can see at the moment.
VHL Price at posting:
0.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)